Skip to main content

Bausch Health Companies Inc

For the period ended Dec 31, 2024. Filed Feb 20, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 20, 2025

BHC$8.40+2.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 2. Properties

We own and lease a number of properties. Our headquarters and one of our manufacturing facilities are located in Laval, Quebec. We own several manufacturing facilities throughout the U.S. We also own or have an interest in manufacturing plants or other properties outside the U.S., including in Canada, Mexico, and certain countries in Europe, Asia and South America.

We consider our facilities to be in satisfactory condition and suitable for their intended use. Our administrative, marketing, research/laboratory, distribution and warehousing facilities are located in various parts of the world. We co-locate our R&D activities with our manufacturing at the plant level in a number of facilities. Our scientists, engineers, quality assurance/quality control professionals and manufacturing technicians work side-by-side in designing and manufacturing products that fit the needs and requirements of our customers, regulators and business units.

We believe that we have sufficient facilities to conduct our operations. Our facilities in aggregate are approximately 10 million square feet and include, among others, the following principal properties:

Bausch Health LocationPurposeOwnedorLeasedApproximateSquareFootage
Laval, Quebec, CanadaCorporate headquarters, R&D, manufacturing and warehouse facilityOwned338,000
Bridgewater, New Jersey(1)Administration shared with Bausch + LombLeased310,000
San Juan del Rio, MexicoOffices and manufacturing facilityOwned853,000
Jelenia Gora, PolandOffices, R&D, manufacturing and warehouse facilityOwned521,000
Rzeszow, PolandOffices, R&D, manufacturing and warehouse facilityOwned380,000
Steinbach, CanadaOffices, manufacturing and warehouse facilityOwned241,000
Bausch + Lomb LocationPurposeOwnedorLeasedApproximateSquareFootage
Vaughan, Ontario, CanadaCorporate headquarters and distribution facilityLeased66,000
Bridgewater, New JerseyAdministration shared with Bausch HealthLeased310,000
Rochester, New YorkOffices, R&D and manufacturing facilityOwned953,000
Waterford, IrelandR&D and manufacturing facilityOwned500,000
Woodruff, South CarolinaDistribution facilityLeased432,000
Jinan, ChinaOffices and manufacturing facilityOwned418,000
Berlin, GermanyR&D, manufacturing, distribution and office facilityOwned339,000
Greenville, South CarolinaManufacturing facilityOwned314,000
Lynchburg, VirginiaOffices and distribution facilityOwned224,000
Aubenas, FranceOffices, manufacturing and warehouse facilityOwned193,000
Tampa, FloridaR&D and manufacturing facilityOwned171,000
St. Louis, MissouriOffices, R&D and manufacturing facilityOwned140,000
Macherio, ItalyOffices, manufacturing and warehouse facilityOwned119,000
Clearwater, FloridaR&D and manufacturing facilityOwned102,000
Beijing, ChinaManufacturing facilityOwned97,000

(1) — A lease for a second building in Bridgewater, New Jersey was signed in 2015 and was not included in the square footage shown in the table above as the Company has never occupied the second building. In 2016, the Company concluded that it would not occupy the second building and recognized the appropriate charge for all future rents due, net of the anticipated sub-let income associated with the second building. In 2023, the Company decided to exercise an option to early terminate the lease period. As a result, the Company recognized an impairment to the right-of-use asset and a charge for the required termination payment.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.